WO2004038017A1 - イソマルトース生成酵素の遺伝子が欠損した、真菌類に属する微生物 - Google Patents
イソマルトース生成酵素の遺伝子が欠損した、真菌類に属する微生物 Download PDFInfo
- Publication number
- WO2004038017A1 WO2004038017A1 PCT/JP2003/013353 JP0313353W WO2004038017A1 WO 2004038017 A1 WO2004038017 A1 WO 2004038017A1 JP 0313353 W JP0313353 W JP 0313353W WO 2004038017 A1 WO2004038017 A1 WO 2004038017A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- gene
- promoter
- microorganism
- isomaltose
- transformant
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2451—Glucanases acting on alpha-1,6-glucosidic bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2405—Glucanases
- C12N9/2408—Glucanases acting on alpha -1,4-glucosidic bonds
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y204/00—Glycosyltransferases (2.4)
- C12Y204/01—Hexosyltransferases (2.4.1)
- C12Y204/01139—Maltose synthase (2.4.1.139)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/0102—Alpha-glucosidase (3.2.1.20)
Definitions
- the present invention relates to microorganisms used for protein production. More particularly, the present invention relates to a microorganism that can be used as a host for producing a protein-producing microorganism, a protein-producing microorganism, and a method for producing a protein using the microorganism.
- filamentous fungi secrete and produce various enzyme proteins outside the cells. Utilizing these characteristics of filamentous fungi, various filamentous fungi including /! Spe / ⁇ ⁇ / i; s genus filamentous fungi have been used in the brewing field such as miso, soy sauce, and sake production and enzyme preparations since ancient times. It has been widely used. Long-term breeding to increase extracellular enzyme production has resulted in strains that can produce tens of grams of enzyme protein per liter of culture.
- the promoter of the amylase gene of Aspergillus cerevisiae (see, for example, JP-A-62-272988 and Biotechnolgy, 5, 368 987), the promoter of the darcoamylase gene of Aspergillus niger, such as Biotechnology, 6, 1419 (1 988)) has been isolated and is available for use. Furthermore, the ability of promoters has been enhanced by introducing enhancers and modifying regulatory regions. The production of gene products depending on the promoter ability as described above has improved the production capacity more efficiently than the capacity enhancement by the conventional breeding method. However, in order to increase the production of extracellular enzyme protein as an absolute production, the breeding of the host strain was further improved by applying a conventional breeding method. Disclosure of the invention
- Aspergillus oryzae Taka-amylase A is a typical inducible enzyme that is induced in starch maltose and suppressed by dulose.
- the induction mechanism of Aspergillus niger amylase A gene has been analyzed in detail, and it has been revealed that transcription induction is controlled by Aray R, and that the true transcription inducer is isomaltose.
- the effect of inducing the Taka-amylase A gene was investigated using starch and maltose as isomaltose sources. It was found that the expression of Taka-amylase A was remarkably higher than that of the transformant into which the DNA was introduced. From these results, it was found that the use of a microorganism deficient in the major isomaltose synthase gene as a host is an extremely effective means for producing a protein encoded by a gene that is induced to be expressed by isomaltose.
- the present invention has been completed based on such knowledge and provides the following configurations.
- a method for producing a protein comprising: BRIEF DESCRIPTION OF THE FIGURES
- Figure 1 shows the sequence of the promoter region of the Taka-amylase A gene (Aspergillus oryzae).
- FIG. 2 is a schematic diagram of the promoter region of the Taka-amylase A gene (Aspergillus sera), showing the location of the transcription factor binding sequence (CCAAT sequence s SRE) and the location of the mutation. Restriction enzyme sites introduced by site-specific mutation are underlined.
- C CAAT is a CCAAT sequence (a binding factor for the broad-range transcription activator (HAP complex))
- SRE is a transcription activator (AmyR) binding factor of amylolytic enzymes
- TATA is a TATA-box
- +1 is Each represents a transcription start point.
- FIG. 3 is a diagram showing a process of preparing an amylase gene expression vector in Example 3.
- FIG. 4 is a table summarizing the results of the amylase activity measurement in Example 4. ND in the table indicates Not Determined. BEST MODE FOR CARRYING OUT THE INVENTION
- a first aspect of the present invention provides a microorganism belonging to a fungus and deficient in a gene of a main isomaltose producing enzyme.
- the microorganism can be used as a host when producing a transformant used for producing a specific protein.
- the “microorganism belonging to fungi” in the present invention is not particularly limited.
- the filamentous fungus means a filamentous fungus in a broad sense, and includes yeast (ascomycetes, terminal fungi, incomplete fungi).
- the “main isomaltose-producing enzyme” in the present invention refers to an enzyme that is most involved in the production of isomaltose in the microorganism.
- the enzyme having the highest activity among these multiple enzymes corresponds to the main isomaltose-forming enzyme here. I do.
- the microorganism according to the present invention only needs to be deficient in at least a gene encoding such an enzyme.
- other microorganisms involved in the production of isomaltose (there may be more than one when there are two or more). Genes may also be deleted.
- Specific examples of the isomaltose-forming enzyme include ⁇ -darcosidase A, -darcosidase B, transrans dulcosidase, dalcamylase, and isopululase.
- the microorganism according to the present invention is selected by selecting an appropriate microorganism from microorganisms existing in nature or obtained from a preservation institution, and performing mutation treatment so that the gene encoding the main isomaltose synthase is deleted.
- As a method for mutation treatment for example, a vector containing a sequence corresponding to the gene to be deleted with a mutation added in advance is prepared, and this is integrated into the chromosome of the host microorganism using genetic engineering techniques.
- a method for disrupting the target gene present on the chromosome of the host microorganism, a site-specific mutation method, or the like can be used.
- a second aspect of the present invention is to introduce a foreign gene using the above microorganism as a host.
- a transformant obtained by introducing a foreign gene whose expression is induced by isomaltose into a microorganism belonging to a fungus and deficient in the gene of the main isomaltose synthase.
- transformants Such a transformant of the present invention can be used for protein production.
- the transformation method used for producing the transformant of the present invention is not particularly limited, and an appropriate one can be selected from known transformation methods. For example, the method of Turner et al. (Gene, 36, 321-331 (1985)) using protoplasted cells can be used. In addition, the method of Gomi et al. (Agric. Biol. Chem., 51, 323-328 (1987)) may be employed.
- the type of vector used is not particularly limited.
- a commercially available vector suitable for transformation in relation to a host may be prepared, and a product into which a desired gene is inserted may be used.
- the vector preferably incorporates a selection marker suitable for selecting a transformant when the host microorganism is transformed. An appropriate selection marker is adopted in relation to the host used.
- Orditin rubamoyltransferase gene argB
- nitrate reductase gene niaD
- amdS acetate amidase gene
- tributofan synthase gene trpC
- dihydrofolate reductase gene DHFR
- drug resistance genes against oligomycin, destomycin, hygromycin and the like can be mentioned as specific examples of the selection marker.
- the foreign gene used in the present invention basically includes a promoter and a structural gene (coding region).
- the promoter of the host microorganism to be transformed In the case where-can be used (including the case where a suitable promoter has been introduced into the host microorganism in advance), those having no promoter region as the exogenous gene of the present invention, that is, those having only the coding region. It is also possible to use one that includes only the code region and the evening / mineral evening region.
- the gene may encode a homologous protein or a gene encoding a heterologous protein.
- the homologous protein means a protein originally produced by the host microorganism.
- a heterologous protein means a protein that the host microorganism does not naturally produce, that is, a protein that is produced only when a gene encoding it is introduced exogenously. It is not necessary that the promoter and the structural gene (coding region) be provided from the same vector during the transformation. That is, by preparing a first vector having an introduction promoter and a second vector having a structural gene for introduction, and performing transformation using both of them, an exogenous target can be obtained. A transformant into which the gene has been introduced may be obtained.
- a modified promoter obtained by modifying a promoter existing in nature can also be used. Specific examples of the modified promoter are shown below. In the following description, a function that can enhance promoter activity is referred to as an “enhancer function”.
- a promoter that functions in a filamentous fungus comprises: a first DNA fragment containing CCAATNNNNNN (first nucleotide sequence: SEQ ID NO: 1); and a second DNA fragment containing CGGNNNNNNNNNGG (second nucleotide sequence: SEQ ID NO: 2).
- a modified promoter inserted is inserted.
- the promoter is so constructed that one first DNA fragment and one second DNA fragment form a pair, and in each pair, the first DNA fragment is located at the 5 ′ end of the promoter.
- N represents one of A, T, C, and G.
- the first DNA fragment and the second DNA fragment in the above modified promoter can be synthesized using, for example, a commercially available DMA synthesizer.
- the promoter can be prepared by PCR using Aspergillus-Lyzae evening light amylase A gene as a promoter region and using an appropriate primer.
- a portion important for the enhancer function is a sequence portion corresponding to the first DNA fragment and the second DNA fragment
- the degree of modification of the sequence portion is preferably small.
- other parts are not expected to be directly involved in the enhancer function, so relatively large modifications are considered to be permitted.
- substitution, deletion, addition and the like of about 1 to 20 bases, preferably 1 to 10 bases, more preferably 1 to 5 bases can be performed.
- Such modifications include the introduction of a restriction enzyme cleavage sequence at the 5 'end, 3' end, or other site, and addition of a sequence encoding a signal peptide.
- a modified promoter can also be prepared by inserting a plurality of first DA fragments and a plurality of second DNA fragments into a promoter that functions in filamentous fungi. In this case, it is preferable to use the same number of the first DNA fragment and the second DNA fragment. In addition, it is preferable that one first DNA fragment and one second DNA fragment form a pair, and that the first DNA fragment is inserted into the promoter such that the first DNA fragment is located on the 5 'end side in each pair.
- the promoter may be modified by inserting a plurality of them. Also in this case, when a promoter having a CCAAT sequence and an SRE is used as the promoter to be modified, it is preferable to insert the DNA fragment into a site other than between these two sequences. By further modifying the promoter by incorporating a plurality of DNA fragments having an enhancer function, further improvement in promoter activity can be expected.
- the type of the promoter functioning in filamentous fungi used for the production of the modified promoter is not particularly limited as long as it has the property of functioning in filamentous fungi.
- promoters of genes encoding proteins in microorganisms such as Aspergillus, Penicillium and Trichoderma can be mentioned.
- promoters of genes encoding ⁇ -amylase, darcoamylase, ⁇ -darcosidase and the like of Aspergillus can be used.
- These promoters are more sensitive to microorganisms carrying them, such as restriction enzyme treatment and PCR. It can be obtained using a biological technique.
- the vector can be obtained from the vector by restriction enzyme treatment or PCR.
- the target protein can be produced by culturing the transformant of the present invention under conditions capable of expressing the introduced foreign gene.
- An appropriate culture medium is used depending on the transformant used. For example, various commercially available media or media to which components necessary for the growth, selection, promotion of protein expression and the like of transformants such as arginine and peridine are added can be used.
- the target protein is recovered from the culture solution or the cells after culturing for a desired time. If it is a secreted protein, it can be recovered from the culture solution, otherwise it can be recovered from the cells.
- the culture supernatant When recovering from a culture solution, for example, the culture supernatant should be filtered and centrifuged to remove insolubles, and then separated and purified by a combination of salting out such as ammonium sulfate precipitation, dialysis, and various types of chromatography. Thus, the desired protein can be obtained.
- the target protein in the case of recovering from the cells, can be obtained by, for example, crushing the cells by pressure treatment, ultrasonic treatment, and the like, and then performing separation and purification in the same manner as described above. The above series of steps (crushing, separation, and purification of the cells) may be performed after the cells have been collected from the culture solution in advance by filtration, centrifugation, or the like.
- Example 1 Purification of ⁇ -dalcosidase B (agdB) and cloning of agdB gene (111) 0! —Purification and enzymatic properties of dalcosidase B
- the cell extract is dialyzed against 20 mM MES-K0H buffer (pH 5.5) containing ImM EDTA and 0.5 mM PMSF, and then equilibrated with 20 mM MES-K0H buffer (pH 5.5) beforehand.
- the protein adsorbed on this column was eluted with a linear gradient of 0-0.5 M NaCI in 200 ml.
- ⁇ _darcosidase activity eluted in 0.1 M NaCI
- the fractions were collected and dialyzed against a 20 mM MES-K0H buffer (pH 5.5) containing 1.5 mM ammonium sulfate, and the active fraction was equilibrated with a Phenyl Sepha rose CL-4B column (1 x 12 cm) and eluted with a linear gradient of 40 ml of 1.5-0 ammonium sulfate.
- the active fraction eluted with 0 mm ammonium sulfate was collected and 20 mM HEPES- After dialysis against K0H buffer-(pH 7.4), the solution was concentrated to 1 ml with Centriprep YM-10. The pull was applied to a Resource Q column previously equilibrated with the same bath sofa.
- This enzyme has a glycosyltransferase activity that regioselectively forms ⁇ -1,6 darcoside bonds in addition to its degradation activity. It shows high hydrolysis activity for maltooligosaccharides and the highest reactivity for maliletotriose, and the reactivity decreases in the order of maltotetraose and maltobenose. It was suggested that maltooligosaccharides with low reactivity had low reactivity. The enzyme also showed hydrolytic activity against isomaltose, nigerose, kojibiose, ⁇ , ⁇ -trehalose. However, it showed little activity against ⁇ -ditrophenyldarcoside and sucrose and starch.
- glucose and multiple glycosyltransfer products were synthesized from maltose by the glycosyltransferase activity of this enzyme. Its major glycosyltransfer products were isomaltose and panose. Six hours after the start of the reaction, a transglycosylation product was produced in an amount equivalent to about 50! Of the maltose added as a substrate, of which 60% was isomaltose. In addition, isomaltose was produced when Kojibi-Seiichi or Nigerose was used as a substrate, and isomaltriose was produced when isomaltose was used as a substrate.
- the purified enzyme was subjected to SDS-PAGE to separate both subunits, and each was electroeluted from acrylamide.
- Each subunit was digested with lysyl endopeptidase, and the resulting peptides were fractionated by ⁇ 5! ⁇ SDS-PAGE and electrophoretically transferred to a PVDF membrane.
- the N-terminal amino acid sequence of each major band was determined by a protein sequencer.
- PCR was performed using A. nidulans chromosome DMA with type I Bramera N1,11. A PCR reaction was performed again using a part of the PCR reaction product and the primers N2 and N12 to amplify a partial (440 bp) DMA fragment of the agc / ⁇ gene.
- the n / 'cfu / a /) s chromosomal DNA was digested with ⁇ /' fld III, and the W / '? Dl II digested DNA fragment was fractionated by size on agarose gel electrophoresis.
- ⁇ -dalcosidase ⁇ is synthesized as a single polypeptide precursor and processed to form a heterodimeric structure.
- the amino acid sequence from the ⁇ -end to the 20th has the typical characteristics of a signal peptide, suggesting that this enzyme is a secretory enzyme.
- Takaamylase ⁇ gene (iaaGZ) 3164 bp [Gene, 84, 319-327 (1989) pTG-taa containing D [Mo Gene. Genet., 254, 119-126 (1997)]
- a Taka-amylase A gene promoter region and a Taka-amylase A gene coding region were prepared.
- a 750 bp fcoR Sa / I fragment containing the Taka-amylase A (iaai ⁇ ) promoter region was obtained from pTG-taa, and this fragment was used as the fcoR of the multicloning site of plasmid pKF18K (Toyobo Co., Ltd.).
- Plasmid pKF-taaP containing Taka-amylase promoter overnight was obtained by inserting into the mouse Sa / I site. This plasmid was used for the operation of introducing a mutation into the promoter overnight region and the construction of the modified promoter overnight region.
- SREf (5'-GACTAGTTAACCTAGGGGCGGAAATTTAACGGGATGTTAACTAGTC-3 ': SEQ ID NO: 15) as a synthetic DNA having Spel site and ///' / 7cl I site added to the 5 'end and 3' end of SRE
- SREr (5′-GACTAGTTAACATCCCGTTAAATTTCCGCCCCTAGGTTAACTAGTC-3 ′: SEQ ID NO: 16) was synthesized as a complementary strand of this sequence, and a DMA fragment containing SRE alone was obtained in the same manner as described above.
- CCAAAT fragment the DNA fragment containing only the CCAAT sequence prepared here
- SRE fragment the DMA fragment containing only SRE
- SEQ ID NO: 9 a DNA fragment containing the region from the CCAAT sequence to the SRE
- PCR was carried out for 30 cycles at 94 ° C for 30 seconds, 54 ° C for 30 seconds, and 72 ° C for 1 minute and 30 seconds.
- rcCAAT-SRE Psi fragment
- JTfto Woil site Piece SEQ ID NO: 1 1.
- rCCAAT- SRE referred Tft 0 Bok / Voil
- Mutagenesis was introduced into the Taka-amylase A gene promoter region as follows. First, in order to introduce a restriction enzyme site for promoter region modification into pKF-taaP prepared in (2-1), the following primers and Mutan-Super Express Km Kit (TA KARA) were used. Site-directed mutagenesis was performed on pKF-taaP.
- the sequence of the wild-type promoter (SEQ ID NO: 12) is shown in FIG. 1, and the position of the introduced restriction enzyme site is shown in FIG.
- a primer for introducing a W oil site into a downstream region location 465 of the evening force amylase promoter shown in SEQ ID NO: 12
- a primer for introducing a Wol site into a region sandwiched between the CCAAT sequence and the SRE (location 252 of the evening force amylase promoter shown in SEQ ID NO: 12);
- a primer for introducing a Spel site into a downstream region (position 490 of the Taka-amylase promoter shown in SEQ ID NO: 12),
- Plasmid pKF-SREb containing the modified promoter-PSREb inserted into the site, the DNA fragment obtained by cleaving the CCAAT-SRE (Psil) fragment prepared in (2-2) with Pst, is the Psti in the downstream region of the promoter.
- Plasmid pKF-PCSb containing a modified open-ended motor PCSb in which the fragment was inserted into the Xfw / Voti site downstream of the promoter was prepared.
- the CCAAT-SRE ( ⁇ ⁇ Woil) fragment was digested with W ⁇ and cut with a Woil, recovered. The purified fragment was inserted into the ⁇ ⁇ ⁇ Woil site downstream of the promoter, and then the CCAAT-SRE ⁇ sil) fragment was removed. Plasmid pKF-PCSPb containing the modified promoter PCSPb in which the CCAAT-SRE fragment was inserted in two places was prepared by insertion into the Psil site.
- FIG. 3 shows the process for preparing the amylase gene expression vector.
- plasmid pU C18 Toyobo Co., Ltd.
- Klenow treatment plasmid P UC18 lacking the Sa / I site by cell Ruch ligated (S-) I got it.
- the fcoRI fragment of the litter force amylase A gene was isolated from the plasmid pTG-taa, and this fragment was inserted into the fcom site of the multicloning site of pUC18 (S-) to obtain pUC-taa (S-). .
- This plasmid pUC-taa (S-) was partially digested with fcoRI to obtain a plasmid pUC-taa in which the fcoRI site at the 3 'end of the taaG gene had been deleted.
- plasmid pBlue (XSE-) in which pBiuescriptl I KS (+) had been deleted and Sa / SaroHI was deleted was obtained.
- an EcoR Hind ⁇ II fragment containing taaG2 was isolated from pUC-taa, and this fragment was inserted into the £ coR I-W / nrfl II site of the multicloning site of the plasmid pBlue (XSE-).
- a plasmid pBIue-taa containing taaG2 was obtained.
- the modified promoter region from the plasmid pKF-taaPM series (pKF-CCAATb, pF-SREb, pKF-PCSP, pKF-PCSb, or pKF-PCSPb) containing the modified promoter obtained in (2-3) was isolated and inserted into the plasmid pBlue-taa multicloning site fcoR Sa / I to obtain the plasmid pBlue-taaM in which the modified promoter region and the taa gene were linked. did.
- the XbaI Bam fragment of the iaaG gene containing the modified promoter was isolated from pBIue-taaM, and the plasmid pBAR7 (pBluescriptl I KS (+) was inserted with the argfl gene lacking the C-terminal from Aspergillus' PBAR-taaM series (pBAR-CC AATb, pBAR-SREb. PBAR-PCSP, pBAR-PCSb, and pBAR-), which are incorporated into the Sa / nHI of the multicloning site of the purified plasmid. PCSPb).
- a plasmid having a wild-type promoter was prepared by the same procedure, and this was designated as pBAR-taa.
- a part (4.9 kb) cl fragment (-3, 132 to +1, 689) of the agrfS gene contained in the plasmid PGBH6 obtained in (1-2) was added to pB I uesc rip 11 I KS (+). It was subcloned to construct pGBS5.
- the 4.9 kb fragment of C / a from W / nd III of pGBH6 (+222 to +4,726) and the / Ipa C / al3.1 kb fragment (-2, 834 to +221) prepared from PGBS5 Then, the plasmid was ligated to C / al-erased pBluescript II KS + to construct pGBA8.
- the agciS gene disruption plasmid PGBAP2 was constructed by replacing the Sa / I1 fragment of pGBA8 (corresponding to -181 to +3,435 of the agciS gene) with the Sspl 2.0 kb fragment containing the crassapy gene.
- the Bsp ⁇ 2.0 kb fragment contains pTG1 containing the pyr4 gene (Mol.Gen. Genet. (1997) 254: 119-126, M. Kato, A. Aoyama, F. Naruse, T. Kobayash i, and N Prepared from Tsukagosh i).
- A. nidulans ABPU1 was transformed to obtain ⁇ aggrfg strain DBP9.
- the insertion of the oyM gene at the site was confirmed by Southern plot analysis. This strain has been deposited as follows.
- Filamentous fungi were transformed as follows. First, the plasmids pBAR-taa, pBAR-PCSb, and pBAR-PCSPb obtained in Example 3 were digested with fcoRV, followed by extraction with phenol / chloroform and ethanol precipitation to obtain purified plasmid. Was used for transformation. Transformation was performed as follows.
- ⁇ -Darcosidase deficient strain DBP9 ((pyrG89) biAl wA3 argB2 pyroA4A agdB :: pyr4) of Aspergillus penidlans obtained in (4-1) and an Aspergillus' two-drance ABPU1 strain (biAI pyrG89) as a control strain wA3 argB2 pyroA4) was added to a complete medium (2% malt extract, 2% glucose, 0.1% peptone) and supplemented with nutrients (arginine, peridine, pyridoxine, and biscuitin) at 37 ° C. C.
- a complete medium 2% malt extract, 2% glucose, 0.1% peptone
- Chromosomal DMA was prepared from each transformant as follows. First, the transformant was cultured overnight at 37 ° C in a medium supplemented with the necessary nutrients (peridine, pyridoxine, and biotin) in a complete medium, and the resulting cells were placed in a Buchner funnel. It was collected with No. 2 filter paper (Advantech) and washed with sterilized water. After removing excess water, the mixture was frozen at -80 ° C and dried using FREEZONE (LABCONCO). After drying, add 1 glass ball and crush it with a multi-beads shocker (Yasui Kikai Co., Ltd.) at 2,000 rpm for 5 minutes to form a fine powder.
- a multi-beads shocker Yasui Kikai Co., Ltd.
- a TE solution containing 0.2 mg / ml proteinase K was further added, and 37 ° (:, This solution was reacted for 30 minutes, extracted with phenol / chloroform, and precipitated with 2.5 volumes of cold ethanol The precipitate was rinsed with 70% ethanol, dried, and dissolved in TE solution.
- Chromosomal DNA solution Southern blot analysis was performed by digesting chromosomal DNA with / lI or fcoRV, separating it by agarose gel electrophoresis, and plotting it on nylon membrane (Roche). Sg / It Sfflal digest was detected as a probe, and probe labeling and signal detection were performed using a DIG nucleic acid detection kit (Roche).
- Amylase productivity using the BPU1 strain as a host was compared by the following procedure.
- each transformant minimal medium (0.9% Na 0 3, 0.05 % KCU 0.15% KH 2 P0 4, 0.
- the amylase activity was determined by adding an enzyme solution to 20 mM sodium acetate buf fer, lOmM CaCI 2 , and 2% Soluble Starch (Nacalai Tesque) to prepare a reaction system for I.
- the amount of reducing sugars produced by reacting at 7 ° C for 20 minutes was quantified by the NeIson-Somogyi method.
- the amount of enzyme that releases ⁇ of glucose per minute was defined as lun.
- the amylase production was determined from the measured amylase activity value, and the amylase productivity was compared between the case where the ⁇ -darcosidase B-deficient strain was used as the host and the case where the ABPU 1 strain was used as the host.
- the amylase activity when cultured in MP medium using maltose as a C source was measured.
- the amount of amylase production is about 7 times that when the ABPU 1 strain is used as a host, and the modified promoter (PCS b Alternatively, the amylase production of the strain incorporating PCS P b) was about twice that of the ABPU1 strain as a host. From these results, it was found that when a C source such as maltose, which easily synthesizes isomaltose, was used in the medium, the amylase producing ability could be further enhanced by using a host lacking the agdB gene.
- a host microorganism capable of efficiently increasing the expression of a gene when the gene is introduced exogenously.
- the target protein can be produced with high productivity.
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Mycology (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Enzymes And Modification Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Abstract
Description
Claims
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US10/532,064 US7341848B2 (en) | 2002-10-23 | 2003-10-20 | Isomaltose synthase-knockout microorganism belonging eumycota |
EP03754178A EP1561813A4 (en) | 2002-10-23 | 2003-10-20 | EUMYCOTA MICROORGANISM WITH ISOMALTOSESYNTHASE KNOCKOUT |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2002-307922 | 2002-10-23 | ||
JP2002307922A JP2004141029A (ja) | 2002-10-23 | 2002-10-23 | イソマルトース生成酵素の遺伝子が欠損した、真菌類に属する微生物 |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2004038017A1 true WO2004038017A1 (ja) | 2004-05-06 |
Family
ID=32170953
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2003/013353 WO2004038017A1 (ja) | 2002-10-23 | 2003-10-20 | イソマルトース生成酵素の遺伝子が欠損した、真菌類に属する微生物 |
Country Status (5)
Country | Link |
---|---|
US (1) | US7341848B2 (ja) |
EP (1) | EP1561813A4 (ja) |
JP (1) | JP2004141029A (ja) |
CN (1) | CN1705742A (ja) |
WO (1) | WO2004038017A1 (ja) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2011067095A (ja) * | 2008-01-10 | 2011-04-07 | Ajinomoto Co Inc | 発酵法による目的物質の製造法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63216493A (ja) * | 1987-03-06 | 1988-09-08 | Nippon Shokuhin Kako Ltd | 高純度イソマルト−スの製造方法 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DK122686D0 (da) | 1986-03-17 | 1986-03-17 | Novo Industri As | Fremstilling af proteiner |
-
2002
- 2002-10-23 JP JP2002307922A patent/JP2004141029A/ja active Pending
-
2003
- 2003-10-20 EP EP03754178A patent/EP1561813A4/en not_active Withdrawn
- 2003-10-20 CN CNA2003801018981A patent/CN1705742A/zh active Pending
- 2003-10-20 WO PCT/JP2003/013353 patent/WO2004038017A1/ja active Application Filing
- 2003-10-20 US US10/532,064 patent/US7341848B2/en not_active Expired - Fee Related
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS63216493A (ja) * | 1987-03-06 | 1988-09-08 | Nippon Shokuhin Kako Ltd | 高純度イソマルト−スの製造方法 |
Non-Patent Citations (7)
Title |
---|
KATO ET AL., BIOSCI. BIOTECHNOL. BIOCHEM., vol. 65, 2001, pages 2340 - 2342 |
KATO ET AL., CURR. GENET., vol. 42, 2002, pages 43 - 50 |
MASASHI KATO, ET AL: "NO FACTORS EXCEPT FOR THE HAP COMPLEX INCREASE THE TAKA-AMYLASE A GENE EXPRESSION BY BINDING TO THE CCAAT SEQUENCE IN THE PROMOTER REGION", BIOSCI. BIOTECHNOL. BIOCHEM., vol. 65, no. 10, 2001, pages 2340 - 2342, XP002974635 * |
NAOKI KATO, ET AL: "ISOMALTOSE FORMED BY ALPHA-GLUCOSIDASES TRIGGERS AMYLASE INDUCTION IN ASPERGILLUS NIDULANS", CURR. GENET., vol. 42, no. 1, 13 September 2002 (2002-09-13), pages 43 - 50, XP002974634 * |
See also references of EP1561813A4 * |
SHUJI TANI, ET AL: "IN VIVO AND IN VITRO ANALYSES OF THE AMYR BINDING SITE OF THE ASPERGILLUS NIDULANS AGDA PROMOTER: REQUIREMENT OF THE CGG DIRECT REPEAT FOR INDUCTION AND HIGH AFFINITY BINDING OF AMYR", BIOSCI. BIOTECHNOL. BIOCHEM., vol. 65, no. 7, 2001, pages 1568 - 1574, XP002974636 * |
TANI ET AL., BIOSCI. BIOTECHNOL. BIOCHEM., vol. 65, 2001, pages 1568 - 1574 |
Also Published As
Publication number | Publication date |
---|---|
EP1561813A1 (en) | 2005-08-10 |
US7341848B2 (en) | 2008-03-11 |
EP1561813A4 (en) | 2007-07-04 |
CN1705742A (zh) | 2005-12-07 |
US20060234338A1 (en) | 2006-10-19 |
JP2004141029A (ja) | 2004-05-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DK2875119T3 (en) | AGSE-DEFICIENT TRIALS | |
CN105189730B (zh) | 淀粉酶缺陷菌株 | |
CN111378585B (zh) | 用于表达外源基因的毕赤酵母突变株 | |
JP2010501181A (ja) | 増加した生産力を伴うプルラナーゼ変異体 | |
JP6537076B2 (ja) | 分泌シグナルペプチドならびにそれを利用したタンパク質の分泌および細胞表層提示 | |
JP2022110110A (ja) | 糸状真菌宿主細胞によって発現された組換えシュウ酸デカルボキシラーゼ | |
KR101779890B1 (ko) | 레반 과당전이효소 생산능이 향상된 균주 및 이를 이용한 디프럭토스 언하이드리드 iv 생산방법 | |
JP2015039349A (ja) | グルコース抑制遺伝子破壊株およびそれを利用した物質の生産方法 | |
WO2004038017A1 (ja) | イソマルトース生成酵素の遺伝子が欠損した、真菌類に属する微生物 | |
JP5507062B2 (ja) | 高発現プロモーター | |
JPH0671428B2 (ja) | ウリカーゼのdna配列および製法 | |
CN113755509A (zh) | 溶血磷脂酶变体及其构建方法和在黑曲霉菌株中的表达 | |
Yano et al. | Deletion of uncharacterized domain from α-1, 3-glucanase of Bacillus circulans KA-304 enhances heterologous enzyme production in Escherichia coli | |
Guo et al. | A food-grade industrial arming yeast expressing β-1, 3-1, 4-glucanase with enhanced thermal stability | |
Yin et al. | Construction of a shuttle vector for heterologous expression of a novel fungal α-amylase gene in Aspergillus oryzae | |
Lim et al. | Recombinant production of an inulinase in a Saccharomyces cerevisiae gal80 strain | |
JP6839424B2 (ja) | 真菌におけるタンパク質の選択的分泌技術 | |
Zhang et al. | Construction of recombinant industrial Saccharomyces cerevisiae strain with bglS gene insertion into PEP4 locus by homologous recombination | |
WO2003080830A1 (fr) | Promoteur modifie | |
WO2012060389A1 (ja) | シゾサッカロミセス属酵母の形質転換体およびその製造方法 | |
KR101826927B1 (ko) | 레반슈크라제 생산능이 향상된 균주 및 이를 이용한 레반 생산방법 | |
JP2003164284A (ja) | 新規エンドグルカナーゼおよびエンドグルカナーゼ遺伝子 | |
CN109715809A (zh) | 在丝状真菌细胞中选择性碳源非依赖性表达蛋白质编码序列的方法 | |
WO2024004983A1 (ja) | エリスリトール資化能欠損変異トリコデルマ属菌、及びこれを用いた目的物質の製造方法 | |
JP2007312618A (ja) | シイタケの保存過程で発現する細胞壁分解酵素関連遺伝子群、及びその利用方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A1 Designated state(s): CN US |
|
AL | Designated countries for regional patents |
Kind code of ref document: A1 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
WWE | Wipo information: entry into national phase |
Ref document number: 20038A18981 Country of ref document: CN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2003754178 Country of ref document: EP |
|
WWP | Wipo information: published in national office |
Ref document number: 2003754178 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2006234338 Country of ref document: US Ref document number: 10532064 Country of ref document: US |
|
WWP | Wipo information: published in national office |
Ref document number: 10532064 Country of ref document: US |